The clinical course of COVID-19 in systemic sclerosis patients, report from 150 patients

por Tamartash, Zahra, Javinani, Ali, Gharibdoost, Farhad, Atef Yekta, Reza, Mohammadzadegan, Amirmohammad, Kavosi, Hoda
Publicado 2021

Herbal medicine IMOD suppresses LPS-induced production of proinflammatory cytokines in human dendritic cells

por Mirzaee, Saeedeh, Drewniak, Agata, Sarrami-Forooshani, Ramin, Kaptein, Tanja M., Gharibdoost, Farhad, Geijtenbeek, Teunis B. H.
Publicado 2015

Analysis of gene expression profiles and protein-protein interaction networks in multiple tissues of systemic sclerosis

por Karimizadeh, Elham, Sharifi-Zarchi, Ali, Nikaein, Hassan, Salehi, Seyedehsaba, Salamatian, Bahar, Elmi, Naser, Gharibdoost, Farhad, Mahmoudi, Mahdi
Publicado 2019

Effects of IMOD™ and Angipars™ on mouse D-galactose-induced model of aging

por Ghanbari, Samane, Yonessi, Mahsa, Mohammadirad, Azadeh, Gholami, Mahdi, Baeeri, Maryam, Khorram-Khorshid, Hamid Reza, Gharibdoost, Farhad, Abdollahi, Mohammad
Publicado 2012

Bundle Branch Blocks and Fragmented QRS Complex in Iranian Patients with Systemic Sclerosis

por Javinani, Ali, Javady Nejad, Zahra, Gharibdoost, Farhad, Jamshidi, Ahmad Reza, Yekta, Reza Atef, Alvand, Saba, Imeni, Vahide, Hashemi, Seyed Naser, Kavosi, Hoda
Publicado 2019

A  Phase IV Study of the Safety and Efficacy of CinnoPar(®) in Iranian Patients with Osteoporosis

por Jamshidi, Ahmadreza, Gharibdoost, Farhad, Sedighi, Sima, Hajiabbasi, Asghar, Salari, Amir-Hossein, Khabbazi, Alireza, Mottaghi, Peyman, Tahammoli Roudsari, Ahmad, Aghaei, Mehrdad, Shenavar Masooleh, Irandokht, Sabzvari, Araz, Anjidani, Nassim
Publicado 2021

A phase III, randomized, two-armed, double-blind, parallel, active controlled, and non-inferiority clinical trial to compare efficacy and safety of biosimilar adalimumab (CinnoRA®)...

por Jamshidi, Ahmadreza, Gharibdoost, Farhad, Vojdanian, Mahdi, Soroosh, Soosan G., Soroush, Mohsen, Ahmadzadeh, Arman, Nazarinia, Mohammad Ali, Mousavi, Mohammad, Karimzadeh, Hadi, Shakibi, Mohammad Reza, Rezaieyazdi, Zahra, Sahebari, Maryam, Hajiabbasi, Asghar, Ebrahimi, Ali Asghar, Mahjourian, Najmeh, Rashti, Amin Mohammadinejad
Publicado 2017

Efficacy and safety of the biosimilar denosumab candidate (Arylia) compared to the reference product (Prolia®) in postmenopausal osteoporosis: a phase III, randomized, two-armed, d...

por Jamshidi, Ahmadreza, Vojdanian, Mahdi, Soroush, Mohsen, Akbarian, Mahmoud, Aghaei, Mehrdad, Hajiabbasi, Asghar, Mirfeizi, Zahra, Khabbazi, Alireza, Alishiri, Gholamhosein, Haghighi, Anousheh, Salimzadeh, Ahmad, Karimzadeh, Hadi, Shirani, Fatemeh, Fard, Mohammad Reza Hatef, Nazarinia, MohammadAli, Soroosh, Soosan, Anjidani, Nassim, Gharibdoost, Farhad
Publicado 2022